*Disclaimer: Contingency fee basis refers only to attorney fees
Current guidelines recommend tirzepatide for weight loss in adults who meet one of the following criteria: A Body Mass Index (BMI) of 30 or higher (classified as obesity), or A BMI of 27 or higher with at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol
To keep the skin tight and robust, support collagen levels with a combination of skincare, supplements, nutrition, and sun protection
,
Clean and fresh atmosphere
Preclinical data in rodent models showed approximately 37% greater hepatic fat reduction versus tirzepatide-equivalent dosing, a finding cited in multiple human trial design rationales as justification for the Retatrutide vs Tirzepatide superiority hypothesis in hepatic metabolic disease contexts